2024 annual financial data
Whitehawk Therapeutics 2024 Net income growth
Direct answer
Net income growth was 3.15%.
Operating income was -67,458,000 USD and net income was -63,691,000 USD.
Operating cash flow was -59,550,000 USD.
Get free Whitehawk Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,983,000 USD
- Operating income
- -67,458,000 USD
- Net income
- -63,691,000 USD
- Operating cash flow
- -59,550,000 USD